RTTNews | Oct 3, 2020 12:50PM EDT

12:49 Saturday, October 3, 2020 (RTTNews) - Apellis Pharma Presents Results Of Post Hoc Analysis Of Phase 2 FILLY Study Of Intravitreal Pegcetacoplan (APL-2)

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2020 RTTNews.com. All Rights Reserved